title: Taurine release in developing mouse hippocampus is modulated by glutathione and glutathione derivatives.
abstract: Glutathione (reduced form GSH and oxidized form GSSG) constitutes an important defense against oxidative stress in the brain, and taurine is an inhibitory neuromodulator particularly in the developing brain. The effects of GSH and GSSG and glycylglycine, gamma-glutamylcysteine, cysteinylglycine, glycine and cysteine on the release of [(3)H]taurine evoked by K+-depolarization or the ionotropic glutamate receptor agonists glutamate, kainate, 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and N-methyl-D-aspartate (NMDA) were now studied in slices from the hippocampi from 7-day-old mouse pups in a perfusion system. All stimulatory agents (50 mM K(+), 1 mM glutamate, 0.1 mM kainate, 0.1 mM AMPA and 0.1 mM NMDA) evoked taurine release in a receptor-mediated manner. Both GSH and GSSG significantly inhibited the release evoked by 50 mM K+. The release induced by AMPA and glutamate was also inhibited, while the kainate-evoked release was significantly activated by both GSH and GSSG. The NMDA-evoked release proved the most sensitive to modulation: L-Cysteine and glycine enhanced the release in a concentration-dependent manner, whereas GSH and GSSG were inhibitory at low (0.1 mM) but not at higher (1 or 10 mM) concentrations. The release evoked by 0.1 mM AMPA was inhibited by gamma-glutamylcysteine and cysteinylglycine, whereas glycylglycine had no effect. The 0.1 mM NMDA-evoked release was inhibited by glycylglycine and gamma-glutamylcysteine. In turn, cysteinylglycine inhibited the NMDA-evoked release at 0.1 mM, but was inactive at 1 mM. Glutathione exhibited both enhancing and attenuating effects on taurine release, depending on the glutathione concentration and on the agonist used. Both glutathione and taurine act as endogenous neuroprotective effectors during early postnatal life.
authors: Brain Research Center, University of Tampere Medical School, Tampere, Finland.
authors: R
authors: R
authors: Janáky
authors: C A
authors: CA
authors: Shaw
authors: S S
authors: SS
authors: Oja
authors: P
authors: P
authors: Saransaari
mesh_terms: D000818:Animals; D005260:Female; D005978:Glutathione / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism*; D008297:Male; D051379:Mice; D011188:Potassium / Q000494:pharmacology; D013654:Taurine / Q000378:metabolism*
chemical_list: D013654:Taurine; D005978:Glutathione; D011188:Potassium
references: Neuroscience. 2000;95(2):617-24
references: 10658641
references: Brain Res Dev Brain Res. 1996 Mar 29;92(1):10-7
references: 8861717
references: Prog Neurobiol. 2000 Nov;62(4):407-25
references: 10856611
references: Amino Acids. 2000;19(3-4):509-26
references: 11140356
references: Neuroscience. 2001;104(4):1043-55
references: 11457589
references: Neurochem Res. 2002 Feb;27(1-2):21-6
references: 11926272
references: Brain Res Dev Brain Res. 2002 Dec 15;139(2):227-36
references: 12480137
references: Amino Acids. 2003;24(1-2):213-21
references: 12624755
references: Adv Exp Med Biol. 2003;526:527-36
references: 12908639
references: Int Rev Neurobiol. 1976;19:75-121
references: 13046
references: J Neurosci Res. 1985;13(3):405-16
references: 3989883
references: Prog Clin Biol Res. 1985;179:53-62
references: 4059224
references: Brain Res. 1986 Oct 29;386(1-2):113-21
references: 2430674
references: Adv Exp Med Biol. 1986;203:349-62
references: 2947421
references: Neurochem Res. 1987 May;12(5):475-82
references: 3587506
references: Exp Brain Res. 1987;68(2):290-8
references: 3691702
references: Brain Res. 1987 Dec 15;465(1-2):277-91
references: 3440208
references: Neurochem Res. 1990 Aug;15(8):797-804
references: 2120601
references: Glia. 1990;3(5):427-32
references: 2146228
references: J Neurosci Res. 1990 Sep;27(1):71-7
references: 2254958
references: Physiol Rev. 1992 Jan;72(1):101-63
references: 1731369
references: Physiol Rev. 1993 Jan;73(1):119-47
references: 8419963
references: Neuroreport. 1993 Apr;4(4):411-4
references: 8499600
references: Neurosci Lett. 1993 Jun 25;156(1-2):153-7
references: 8414178
references: Neurosci Lett. 1993 Nov 26;163(1):89-92
references: 8295742
references: J Neurochem. 1994 Jul;63(1):155-60
references: 8207424
references: J Neurochem. 1995 Feb;64(2):531-9
references: 7830045
references: J Neurochem. 1995 Mar;64(3):1088-96
references: 7861138
references: Metab Brain Dis. 1996 Jun;11(2):153-64
references: 8776717
references: Neuroreport. 1996 Apr 26;7(6):1149-52
references: 8817521
references: Trends Neurosci. 1996 Aug;19(8):339-45
references: 8843603
references: Adv Exp Med Biol. 1999;468:49-67
references: 10635019
references: Nature. 2000 May 11;405(6783):187-91
references: 10821275
references: J Biol Chem. 2006 Mar 31;281(13):8864-70
references: 16455645
references: Brain Res. 2005 Mar 21;1038(2):123-31
references: 15757628
references: Hum Reprod. 1999 Sep;14(9):2350-6
references: 10469709
references: J Neurochem. 1999 Sep;73(3):889-902
references: 10461878
references: Amino Acids. 1999;16(2):165-79
references: 10319187
references: Mech Ageing Dev. 1997 Dec 30;99(3):219-32
references: 9483494
references: Neuroscience. 1997 Aug;79(3):847-54
references: 9219947
references: FEBS Lett. 1997 Mar 24;405(2):245-8
references: 9089299
references: J Neurochem. 1996 Dec;67(6):2335-45
references: 8931465
references: Brain Res. 1991 May 17;549(1):1-8
references: 1893243